Women Leadership in Biotech (WLIB)

Supporting women leadership in biotech across a wide range of topics advancing medicine development.

Lead Podcast

How Regeneron Got an FDA-Approved Therapy for COVID in Record Time

Bari Kowal discusses how Regeneron got an FDA-approved COVID therapy in record time and how to drive greater efficiencies in clinical development.

A Vision for the Integration of Clinical Research and Care

How NYU Perlmutter is Rewriting the Way We Work Together to Integrate Clinical Care and Research

Leadership Lessons: Driving Innovation to Support Patients and Sites

Leveraging Mobile Technologies in the Development of Novel Digital Endpoints

Pharmatalk Radio Podcasts

Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities

Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies

Enhancing the Interferon Pathway to Attack Cancer – Not a One-Size-Fits-All Approach

Using Neoadjuvant Immune Checkpoint Blockade as a Window into Treatment Response and Primary Resistance

Sanofi's New Initiatives Embed Patient Voices and Priorities from Discovery to Patient Access

Legal Barriers to Patient Involvement and Potential Pathways to Overcome Them

Advancements in CAR T for the Treatment of Glioblastoma

Biotech CMO-CEO Fireside Discussion on Working Through Challenges

Making Institutional Changes to Offer Clinical Research Options for a Wider Range of Patients

From Bench to Bedside and Beyond: Infusing Patient Perspectives Across Pfizer

Supporting women leadership in biotech across a wide range of topics advancing medicine development.

Lead Podcast

How Regeneron Got an FDA-Approved Therapy for COVID in Record Time

Featured Podcasts

A Vision for the Integration of Clinical Research and Care

How NYU Perlmutter is Rewriting the Way We Work Together to Integrate Clinical Care and Research

Leadership Lessons: Driving Innovation to Support Patients and Sites

Leveraging Mobile Technologies in the Development of Novel Digital Endpoints

More Related Content

Pharmatalk Radio Podcasts

Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities

Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies

Enhancing the Interferon Pathway to Attack Cancer – Not a One-Size-Fits-All Approach

Using Neoadjuvant Immune Checkpoint Blockade as a Window into Treatment Response and Primary Resistance

Sanofi's New Initiatives Embed Patient Voices and Priorities from Discovery to Patient Access

Legal Barriers to Patient Involvement and Potential Pathways to Overcome Them

Advancements in CAR T for the Treatment of Glioblastoma

Biotech CMO-CEO Fireside Discussion on Working Through Challenges

Making Institutional Changes to Offer Clinical Research Options for a Wider Range of Patients

From Bench to Bedside and Beyond: Infusing Patient Perspectives Across Pfizer

Subscribe for More Information

Search By Type:

Search By Category:

Search Within Date Range:

Supporting women leadership in biotech across a wide range of topics advancing medicine development.

Lead Podcast

How Regeneron Got an FDA-Approved Therapy for COVID in Record Time

Featured Podcasts

A Vision for the Integration of Clinical Research and Care

How NYU Perlmutter is Rewriting the Way We Work Together to Integrate Clinical Care and Research

Leadership Lessons: Driving Innovation to Support Patients and Sites

Leveraging Mobile Technologies in the Development of Novel Digital Endpoints

More Related Content

Pharmatalk Radio Podcasts

Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities

Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies

Enhancing the Interferon Pathway to Attack Cancer – Not a One-Size-Fits-All Approach

Using Neoadjuvant Immune Checkpoint Blockade as a Window into Treatment Response and Primary Resistance

Sanofi's New Initiatives Embed Patient Voices and Priorities from Discovery to Patient Access

Legal Barriers to Patient Involvement and Potential Pathways to Overcome Them

Advancements in CAR T for the Treatment of Glioblastoma

Biotech CMO-CEO Fireside Discussion on Working Through Challenges

Making Institutional Changes to Offer Clinical Research Options for a Wider Range of Patients

From Bench to Bedside and Beyond: Infusing Patient Perspectives Across Pfizer

Subscribe for More Information